Bifidobacterium breve के लिए Irritable Bowel Syndrome (IBS)

Q: Does Bifidobacterium breve help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Bifidobacterium breve may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

Q: How much Bifidobacterium breve should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.

Q: Are there side effects of Bifidobacterium breve?

Reported side effects may include Mild gas during initial use, Occasional loose stools in infants (transient), Rare abdominal discomfort, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

Q: How strong is the evidence for Bifidobacterium breve and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is positive.

Limited data from small studies. Preliminary evidence for symptom improvement.

𝕏 LinkedIn

<\/script>\n

`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dbifidobacterium\u002Dbreve\u0026condition\u003Dibs'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style

Widget powered by . Free, no account required.

निष्कर्ष

Limited data from small studies. Preliminary evidence for symptom improvement.

Key Study Findings

Review

Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases.

Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Other n=1098 8 weeks Open-label

A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of …

Dose: None बनाम: None (single-arm open-label) Outcome: Treatment success for abdominal pain and bloating प्रभाव: 73% pain, 81.9% bloating success at T1 <0.001

जनसंख्या: IBS patients from 52 Italian gastroenterologists

Randomized Controlled Trial n=61 8 weeks Double-blind

Eight weeks of treatment with probiotic Bifidobacterium breve, Bif195 lowers fatigue scores in patients with …

Dose: None बनाम: Placebo Outcome: IBS-SSS symptom severity score change प्रभाव: None None

जनसंख्या: Patients with moderate-severe diarrhea-predominant IBS

Randomized Controlled Trial 4 weeks

Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group …

Dose: 2 g बनाम: Placebo Outcome: Constipation symptoms प्रभाव: None P = 0.005

जनसंख्या: IBS patients

Review

Postbiotics: A new member in the biotics family.

Dose: None बनाम: None Outcome: Clinical applications overview प्रभाव: None None

जनसंख्या: General population (review)

In Vitro

Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal …

Dose: None बनाम: None Outcome: Colitis severity प्रभाव: None None

जनसंख्या: Crohn's disease patients

Key Statistics

अध्ययन

150

प्रतिभागी

↑

Positive

ग्रेड

Referenced Papers

Compendium of Bifidobacterium-based probiotics: characteristics and therapeutic impact on human diseases. Review

Microbiome research reports 2025 16 उद्धरण

A multicenter real-world, open-label study assessing the impact of a probiotic mixture on symptoms of irritable bowel syndrome in adults. Other

Beneficial microbes 2025

Eight weeks of treatment with probiotic Bifidobacterium breve, Bif195 lowers fatigue scores in patients with diarrhoea-predominant irritable bowel syndrome: results … Other

Frontiers in nutrition 2025

Bowel Inflammation and Nutrient Supplementation: Effects of a Fixed Combination of Probiotics, Vitamins, and Herbal Extracts in an In Vitro … Other

The Yale journal … 2024 5 उद्धरण

Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study. Other

Journal of neurogastroenterology … 2024 4 उद्धरण

Postbiotics: A new member in the biotics family. Other

Archivos argentinos de … 2024 3 उद्धरण

Gut Microbiome Alterations Following Oral Serum-Derived Bovine Immunoglobulin Administration in the Management of Dysbiosis. Other

Cureus 2024 1 उद्धरण

Alternation of the gut microbiota in irritable bowel syndrome: an integrated analysis based on multicenter amplicon sequencing data. Other

Journal of translational … 2023 30 उद्धरण

Dose-Response Efficacy and Mechanisms of Orally Administered Bifidobacterium breve CCFM683 on IMQ-Induced Psoriasis in Mice. Other

Nutrients 2023 19 उद्धरण

Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: … Other

Journal of neurogastroenterology … 2022 21 उद्धरण

Immunomodulatory Effects of Bifidobacterium spp. and Use of Bifidobacterium breve and Bifidobacterium longum on Acute Diarrhea in Children. Other

Journal of microbiology … 2022 15 उद्धरण

Serpin-positive Bifidobacterium breve CNCM I-5644 improves intestinal permeability in two models of irritable bowel syndrome. Other

Scientific reports 2022 14 उद्धरण

Effectiveness of Probiotics in Children With Functional Abdominal Pain Disorders and Functional Constipation: A Systematic Review. Systematic Review

Journal of clinical … 2018 34 उद्धरण

Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a … Other

Journal of clinical … 2015 62 उद्धरण

Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. Meta-Analysis

Revista espanola de … 2013 102 उद्धरण

The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, … RCT

Journal of clinical … 2012 207 उद्धरण

Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel … Other

PloS one 2012 31 उद्धरण

BDNF expression in the hippocampus of maternally separated rats: does Bifidobacterium breve 6330 alter BDNF levels? Other

Beneficial microbes 2011 89 उद्धरण

The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Other

Neurogastroenterology and motility 2010 213 उद्धरण

Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. RCT

BMC gastroenterology 2010 91 उद्धरण

Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome. RCT

Alimentary pharmacology & … 2007 102 उद्धरण

Clinical studies on alleviating the symptoms of irritable bowel syndrome. RCT

Asia Pacific journal … 2006

A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. RCT

Alimentary pharmacology & … 2005 398 उद्धरण

Probiotics in the treatment of irritable bowel syndrome. RCT

Journal of clinical … 2004 205 उद्धरण

Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome … Other

Research in microbiology 2001 201 उद्धरण

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:: 1-10 billion CFU/day
adultgisupport:: 5-10 billion CFU/day
neonatalsupport:: 1-5 billion CFU/day (as directed by pediatrician)

अधिकतम सीमा: Well-tolerated up to 10 billion CFU/day in clinical trials

अनुसंधान में अध्ययन की गई खुराकें

खुराक	अवधि	प्रभाव	N
None	--	Mixed	--
None	8 weeks	Positive	1098
None	8 weeks	Neutral	61
2 g	4 weeks	Mixed	--
None	--	Positive	--
None	--	Positive	--
Serum-derived bovine immunoglobulin (SBI)	--	Positive	--
None	--	Positive	--

सेवन का सर्वोत्तम समय: Before meals or on empty stomach; for infants, mix with breast milk or formula

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

⚠ Mild gas during initial use
⚠ Occasional loose stools in infants (transient)
⚠ Rare abdominal discomfort
⚠ Very rare: bacteremia in immunocompromised individuals

ज्ञात अंतःक्रियाएँ

● Antibiotics (may reduce probiotic viability; space dosing 2 hours apart)
● Immunosuppressants (use with caution in immunocompromised patients)

सहनीय अधिकतम सेवन: Well-tolerated up to 10 billion CFU/day in clinical trials

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Bifidobacterium breve help with Irritable Bowel Syndrome (IBS)?

Based on 2 studies with 150 participants, there is preliminary evidence that needs more research that Bifidobacterium breve may support Irritable Bowel Syndrome (IBS) management. Our evidence grade is D (Very Early Research).

How much Bifidobacterium breve should I take for Irritable Bowel Syndrome (IBS)?

Studies have used various dosages. A commonly studied range is 1-10 billion CFU/day. Always consult your healthcare provider before starting any supplement regimen.

Are there side effects of Bifidobacterium breve?

Reported side effects may include Mild gas during initial use, Occasional loose stools in infants (transient), Rare abdominal discomfort, Very rare: bacteremia in immunocompromised individuals. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.

How strong is the evidence for Bifidobacterium breve and Irritable Bowel Syndrome (IBS)?

We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 150 total participants. The overall direction of effect is positive.

Related Evidence

इसके लिए अन्य सामग्री Irritable Bowel Syndrome (IBS)

Peppermint Oil A Lactobacillus rhamnosus GG B Psyllium Husk B Lactobacillus plantarum B Partially Hydrolyzed Guar Gum (PHGG) B Bifidobacterium longum B

संक्षिप्त निष्कर्ष

Limited data from small studies. Preliminary evidence for symptom improvement.

Evidence Strength30%

Low confidence

अध्ययन विश्लेषण

RCT (6)Meta (1)Other (0)

विकल्पों की तुलना करें

देखें कि इस स्वास्थ्य स्थिति के लिए अन्य सामग्री की तुलना कैसे है।

इसके लिए सभी सामग्री देखें Irritable Bowel Syndrome (IBS)

अधिक जानें

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।